News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novogen Limited (NVGN) To Present At 2nd Annual Sachs Cancer Bio Partnering & Investment Forum In New York


3/12/2014 9:34:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SYDNEY, March 12, 2014 /PRNewswire/ -- Novogen Limited (ASX: NRT; NASDAQ: NVGN), an oncology drug development company, today announced that Graham Kelly, Ph.D., Executive Director and Chief Executive Officer, will present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum. Dr. Kelly's presentation will take place at 2:30 p.m. on Wednesday, March 19, 2014 at the New York Academy of Sciences in New York City.

Novogen Logo. (PRNewsFoto/Novogen Limited)

About Novogen Limited
Novogen is a public, Australian biotechnology company whose shares trade on both the Australian Securities Exchange ('NRT') and NASDAQ ('NVGN'). The Company is based in Sydney, Australia, and with a U.S. office in New Haven, Connecticut. The Company has two main drug technology platforms known as super-benzopyrans (SBP) and anti-tropomyosins (ATM). SBP drugs target cancer stem cells and are being developed for the treatment of ovarian cancer and glioblastoma. ATM drugs target the cancer cell cytoskeleton and are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. Novogen has entered into a joint venture with Yale University known as CanTx Inc. with the aim of developing personalized chemotherapy for patients with ovarian cancer.

Further information is available on the Company's website, www.novogen.com.

For Further Information Contact:

Investors

Media



In the USA

In the USA

David Carey/Tanner Kauffman

Hollister Hovey/Allison Parks

Lazar Partners

Lazar Partners

+1 212-867-1762

+1 212-867-1762

Novogen@lazarpartners.com

Novogen@lazarpartners.com



In Australia

In Australia

Rudi Michelson

Dr Douglas Pretsell

Monsoon Communications

Instinctif Partners

03 9620 3333

+61(0)3 9657 0706

rudim@monsoon.com.au





In ROW


Sue Charles/Stefanie


Instinctif Partners


+44 (0)20 7457 2020

Logo - http://photos.prnewswire.com/prnh/20131220/NY36990LOGO

SOURCE Novogen Limited



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES